Matches in SemOpenAlex for { <https://semopenalex.org/work/W3194466021> ?p ?o ?g. }
- W3194466021 endingPage "111580" @default.
- W3194466021 startingPage "111580" @default.
- W3194466021 abstract "In this report, we synthesized three new iridium(III) complexes: [Ir(piq) 2 (apip)]PF 6 ( Ir1 , piq = 1-phenylisoquinoline, apip = 2-aminophenyl-1 H -imidazo[4,5-f][1,10]phenanthroline), [Ir(piq) 2 (maip)]PF 6 ( Ir2 , maip = 3-aminophenyl-1 H -imidazo[4,5-f][1,10]phenanthroline) and [Ir(piq) 2 (paip)]PF 6 ( Ir3 , paip = 4-aminophenyl-1 H -imidazo[4,5-f][1,10]phenanthroline). The DNA binding was investigated. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method was used to detect the cytotoxic activity of Ir1 , Ir2 and Ir3 , the complexes show highly active against B16 cells with IC 50 values of 0.3 ± 0.2 μM, 3.7 ± 0.2 μM and 4.6 ± 1.1 μM, respectively. Subsequently, cellular uptake suggested that the cytotoxicity of the complexes is attributed to their differences in cellular uptake levels. In addition, complexes Ir1 , Ir2 and Ir3 induce cell cycle arrest at the G0/G1 phase and regulate the cell cycle mediators such as cyclin D1, CDK6 (cyclin-dependent kinase 6), CDK4 and p21, leading to the inhibition of B16 cells proliferation. The autophagy was investigated by monodansylcadaverine (MDC) staining. The complexes can promote the change from LC3-I to LC3-II, up-regulate levels of Beclin-1 and down-regulate expression of p62. The complexes induced apoptosis by regulating the expression levels of related indicators such as PARP (poly ADP-ribose polymerase), PI3K (phosphoinositide-3 kinase), AKT (protein kinase B), Caspase, Bcl-2 (B-cell lymphoma-2), Bad (Bcl2 associated death promoter), Bax (Bcl2-associated X) and Cyto C (cytochrome C). Additionally, Ir1 exerted significant antitumor activity in the suppression of malignant melanoma proliferation in vivo. As indicated in the above results, these complexes were highly effective for malignant melanoma treatment through the intrinsic pathway and provided much insight into anticancer drugs for tumor therapy. Three new iridium(III) complexes: [Ir(piq) 2 (apip)]PF 6 ( Ir1 , piq = 1-phenylisoquinoline, apip = 2-aminophenyl-1 H -imidazo[4,5-f][1,10]phenanthroline), [Ir(piq) 2 (maip)]PF 6 ( Ir2 , maip = 3-aminophenyl-1 H -imidazo[4,5-f][1,10]phenanthroline) and [Ir(piq) 2 (paip)]PF 6 ( Ir3 , paip = 4-aminophenyl-1 H -imidazo[4,5-f][1,10]phenanthroline) were synthesized and characterized. The cytotoxicity of the complexes against B16 cancer cells were investigated. Ir1 shows high antitumor activity with an inhibitory of 89.12%. • Three new iridium(III) complexes were synthesized and characterized. • The cytotoxicity in vitro and in vivo of the complexes was investigated. • The apoptosis and cell cycle arrest were assayed by flow cytometry. • The expression of B-cell lymphoma-2 family proteins was investigated by western blot. • The antitumor in vivo shows that Ir1 exhibits high antitumor efficiency." @default.
- W3194466021 created "2021-08-30" @default.
- W3194466021 creator A5002188808 @default.
- W3194466021 creator A5004283796 @default.
- W3194466021 creator A5028541140 @default.
- W3194466021 creator A5066786495 @default.
- W3194466021 creator A5066834128 @default.
- W3194466021 creator A5079382582 @default.
- W3194466021 creator A5086396766 @default.
- W3194466021 creator A5091841028 @default.
- W3194466021 date "2021-11-01" @default.
- W3194466021 modified "2023-10-09" @default.
- W3194466021 title "DNA binding and evaluation of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes" @default.
- W3194466021 cites W161836838 @default.
- W3194466021 cites W1777880594 @default.
- W3194466021 cites W1970184435 @default.
- W3194466021 cites W1980792888 @default.
- W3194466021 cites W1983965827 @default.
- W3194466021 cites W1985921689 @default.
- W3194466021 cites W1988691170 @default.
- W3194466021 cites W2015583071 @default.
- W3194466021 cites W2019528169 @default.
- W3194466021 cites W2024105041 @default.
- W3194466021 cites W2026875674 @default.
- W3194466021 cites W2027389851 @default.
- W3194466021 cites W2037123212 @default.
- W3194466021 cites W2039044036 @default.
- W3194466021 cites W2044851985 @default.
- W3194466021 cites W2060517372 @default.
- W3194466021 cites W2073131323 @default.
- W3194466021 cites W2083436950 @default.
- W3194466021 cites W2108300681 @default.
- W3194466021 cites W2114918609 @default.
- W3194466021 cites W2127429864 @default.
- W3194466021 cites W2138236417 @default.
- W3194466021 cites W2145645777 @default.
- W3194466021 cites W2160165060 @default.
- W3194466021 cites W2172162633 @default.
- W3194466021 cites W2567294122 @default.
- W3194466021 cites W2579745428 @default.
- W3194466021 cites W2587048937 @default.
- W3194466021 cites W2596221192 @default.
- W3194466021 cites W2625574648 @default.
- W3194466021 cites W2726771194 @default.
- W3194466021 cites W2741409875 @default.
- W3194466021 cites W2756337976 @default.
- W3194466021 cites W2767643000 @default.
- W3194466021 cites W2769731327 @default.
- W3194466021 cites W2792350317 @default.
- W3194466021 cites W2793703146 @default.
- W3194466021 cites W2794255052 @default.
- W3194466021 cites W2800746297 @default.
- W3194466021 cites W2804421876 @default.
- W3194466021 cites W2884909153 @default.
- W3194466021 cites W2885248588 @default.
- W3194466021 cites W2892098340 @default.
- W3194466021 cites W2896130004 @default.
- W3194466021 cites W2910892797 @default.
- W3194466021 cites W2927760514 @default.
- W3194466021 cites W2947920031 @default.
- W3194466021 cites W2948509699 @default.
- W3194466021 cites W2957145801 @default.
- W3194466021 cites W2965008467 @default.
- W3194466021 cites W2973142158 @default.
- W3194466021 cites W2989126298 @default.
- W3194466021 cites W2993299326 @default.
- W3194466021 cites W2998793527 @default.
- W3194466021 cites W3018491060 @default.
- W3194466021 cites W3021593664 @default.
- W3194466021 cites W3031110778 @default.
- W3194466021 cites W3092628075 @default.
- W3194466021 cites W4247876789 @default.
- W3194466021 doi "https://doi.org/10.1016/j.jinorgbio.2021.111580" @default.
- W3194466021 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34438219" @default.
- W3194466021 hasPublicationYear "2021" @default.
- W3194466021 type Work @default.
- W3194466021 sameAs 3194466021 @default.
- W3194466021 citedByCount "14" @default.
- W3194466021 countsByYear W31944660212021 @default.
- W3194466021 countsByYear W31944660212022 @default.
- W3194466021 countsByYear W31944660212023 @default.
- W3194466021 crossrefType "journal-article" @default.
- W3194466021 hasAuthorship W3194466021A5002188808 @default.
- W3194466021 hasAuthorship W3194466021A5004283796 @default.
- W3194466021 hasAuthorship W3194466021A5028541140 @default.
- W3194466021 hasAuthorship W3194466021A5066786495 @default.
- W3194466021 hasAuthorship W3194466021A5066834128 @default.
- W3194466021 hasAuthorship W3194466021A5079382582 @default.
- W3194466021 hasAuthorship W3194466021A5086396766 @default.
- W3194466021 hasAuthorship W3194466021A5091841028 @default.
- W3194466021 hasConcept C109316439 @default.
- W3194466021 hasConcept C153911025 @default.
- W3194466021 hasConcept C184235292 @default.
- W3194466021 hasConcept C185592680 @default.
- W3194466021 hasConcept C190283241 @default.
- W3194466021 hasConcept C199649820 @default.
- W3194466021 hasConcept C199835354 @default.
- W3194466021 hasConcept C202751555 @default.